Patents by Inventor Matthew LIPSCOMB

Matthew LIPSCOMB has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230033275
    Abstract: This invention relates to metabolically engineered microorganism strains, such as bacterial strains, in which there is an increased utilization of malonyl-CoA for production of a fatty acid or fatty acid derived product, wherein the modified microorganism produces fatty acyl-CoA intermediates via a malonyl-CoA dependent but malonyl-ACP independent mechanism.
    Type: Application
    Filed: June 29, 2022
    Publication date: February 2, 2023
    Applicant: CARGILL, INCORPORATED
    Inventors: Michael D. LYNCH, Michael Tai Man LOUIE, Shelley COPLEY, Eileen Colie SPINDLER, Brittany ROBINSON, Matthew LIPSCOMB, Tanya LIPSCOMB-WARNECKE, Hans H. LIAO, David HOGSETT, Ron EVANS
  • Patent number: 11408013
    Abstract: This invention relates to metabolically engineered microorganism strains, such as bacterial strains, in which there is an increased utilization of malonyl-CoA for production of a fatty acid or fatty acid derived product, wherein the modified microorganism produces fatty acyl-CoA intermediates via a malonyl-CoA dependent but malonyl-ACP independent mechanism.
    Type: Grant
    Filed: June 26, 2019
    Date of Patent: August 9, 2022
    Assignee: CARGILL, INCORPORATED
    Inventors: Michael Lynch, Michael Louie, Shelley Copley, Eileen Spindler, Brittany Robinson, Matthew Lipscomb, Tanya Lipscomb-Warnecke, Hans Liao, David Hogsett, Ron Evans
  • Publication number: 20200048666
    Abstract: This invention relates to metabolically engineered microorganism strains, such as bacterial strains, in which there is an increased utilization of malonyl-CoA for production of a fatty acid or fatty acid derived product, wherein the modified microorganism produces fatty acyl-CoA intermediates via a malonyl-CoA dependent but malonyl-ACP independent mechanism.
    Type: Application
    Filed: June 26, 2019
    Publication date: February 13, 2020
    Applicant: CARGILL, INCORPORATED
    Inventors: Michael LYNCH, Michael LOUIE, Shelley COPLEY, Eileen SPINDLER, Brittany PRATHER, Matthew LIPSCOMB, Tanya LIPSCOMB, Hans LIAO, Dave HOGSETI, Ron EVANS
  • Patent number: 10337038
    Abstract: This invention relates to metabolically engineered microorganism strains, such as bacterial strains, in which there is an increased utilization of malonyl-CoA for production of a fatty acid or fatty acid derived product, wherein the modified microorganism produces fatty acyl-CoA intermediates via a malonyl-CoA dependent but malonyl-ACP independent mechanism.
    Type: Grant
    Filed: July 18, 2014
    Date of Patent: July 2, 2019
    Assignee: CARGILL, INCORPORATED
    Inventors: Michael Lynch, Michael Louie, Shelley Copley, Eileen Spindler, Brittany Prather, Matthew Lipscomb, Tanya Lipscomb, Hans Liao, Dave Hogsett, Ron Evans
  • Publication number: 20160257975
    Abstract: This invention relates to metabolically engineered microorganism strains, such as bacterial strains, in which there is an increased utilization of malonyl-CoA for production of a fatty acid or fatty acid derived product, wherein the modified microorganism produces fatty acyl-CoA intermediates via a malonyl-CoA dependent but malonyl-ACP independent mechanism.
    Type: Application
    Filed: July 18, 2014
    Publication date: September 8, 2016
    Applicant: Cargill, Incorporated
    Inventors: Michael LYNCH, Michael LOUIE, Shelley COPLEY, Eileen SPINDLER, Brittany PRATHER, Matthew LIPSCOMB, Tanya LIPSCOMB, Hans LIAO, Dave HOGSETT, Ron EVANS